About us
Welcome to the newest virtual home of the Philadelphia Area Java Users’ Group, twice rated by Sun as one of the world’s top Java User Groups! The Philly JUG’s main objective is to provide great learning events for our membership, and if you look at our history we’ve done just that. Over the past fifteen+ years the Philly JUG has done quite a bit of growing up. Very few of you might remember our first meeting, where about 35 members sat on the floor in the office of a long departed dot com. If you have been to a meeting recently you know how far we have come.
Current Philly JugMaster: Greg Taylor.
Upcoming events
1
The Art of Debugging in the Era of AI
Certara, 4 Radnor Corporate Center, Suite 350, 100 Matsonford Road, Radnor, PA, USAI coding tools are accelerating development; but they're also shipping code that developers don't fully understand, hiding subtle bugs that slip past regular testing cycles. Every AI-generated line still needs to be tested, validated, and verified before it reaches production. That makes debugging more critical than ever, not less. This session draws on real-world experience solving complex production issues for debugging as a systematic discipline. Attendees will walk away with practical approaches across three areas: mindset, techniques, and tools. This includes learning how to use ChatGPT and LLMs to analyze errors, and how tools like Charles Proxy, Datadog, and Postman fit into a modern debugging workflow. Debug smarter, faster, and with more confidence in the AI era and beyond.
About the Speaker
Bhupendra Mishra
Bhupendra is a Senior Staff Software Engineer at SiriusXM with nearly 20 years of experience building software at scale. He has led mobile platform development, driven system architecture decisions, and guided teams through microservice transformations across multiple industries. His talks draw on real engineering trade-offs; the messy decisions behind systems that actually ship and hold up over time.About the Sponsor
Certara (https://www.certara.com)
Certara accelerates medicines to patients, using biosimulation (modeling and simulation) and technology-enabled services to transform drug discovery and development. Our integrated and proprietary end-to-end platform with generative AI technology, biosimulation, regulatory science, and market access solutions combined with our global 1,400+ strong team of scientists and experts enable informed decision-making, higher R&D productivity, and improved patient outcomes.20 attendees
Past events
120
Group links
Organizers
Members
3,245
